- recruitingPHASE1, PHASE2
AGILE (Early Phase Platform Trial for COVID-19)
The AGILE trial is exploring new treatments for COVID-19. It tests several different medicines to see which ones are safe and work best. Researchers can easily add new promising drugs to the study as they are discovered, aiming to find effective ways to tackle the virus.
South Africa · United Kingdom - recruitingPHASE3
The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients
This study looks at whether high doses of vitamin D3 can help seriously ill adults in intensive care, especially those with very low vitamin D. Previous research hinted it might reduce deaths in this specific group, and this new study aims to confirm if it’s a safe and effective treatment.
Austria · Belgium · Germany - recruitingPHASE3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
This study is testing a new treatment called anti-COVID-19 immunoglobulin (hIVIG) for adults recently diagnosed with COVID-19 who don't need hospital care. Researchers want to see if hIVIG is safe and effective in preventing severe illness compared to a dummy treatment (placebo).
United States · Argentina · Australia - active not recruiting
CCP Cancer UK Companion Study
This study looks at how COVID-19 affects people with cancer in the UK. We want to understand their symptoms, treatment, and recovery, comparing them to people without cancer. This helps us learn how to better care for cancer patients during outbreaks.
United Kingdom - recruiting
Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg)
This study wants to create a new way to measure how COVID-19 affects people's lives after they've recovered. They need people who have had COVID-19 to share their experiences and help design this new tool. It will help understand long-term effects.
United Kingdom - active not recruitingNA
Urine Alkalinisation in COVID-19
This study looks at whether a simple treatment called sodium bicarbonate can protect the kidneys of very sick COVID-19 patients. We know kidney problems are common with severe COVID-19. This research wants to see if making blood less acidic might help prevent this serious issue.
United Kingdom - active not recruiting
Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
This study looks at the health of people in England and Wales one year after they left intensive care for COVID-19. Researchers will compare their health to people who were in intensive care for other reasons. The aim is to understand long-term health effects.
United Kingdom